Skip to the page

Data / Form D filings / Bioverge Funds, Modulo I, LLC

Bioverge Funds, Modulo I, LLC: Form D filing

Bioverge Funds, Modulo I, LLC, an investing company in Boise, ID, filed a Form D with the SEC in 2023. The latest, on March 17, 2023, reports $107,500 sold of a $125,000 offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
222 N 13TH ST, Boise, ID, 83707
Phone
(208) 696-1262
Industry
Investing
Entity type
Limited Liability Company
Incorporated in
Idaho
Year incorporated
2023
Revenue range
Not Applicable
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1969792

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 17, 2023New notice$125,000$107,500$17,50010Mar 13, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Neil - Bioverge Funds Management, LLC - LittmanExecutive Officer

Every Form D from the week of Mar 13, 2023 · All recent filings in Idaho · All recent Investing filings

Read from SEC EDGAR. Amount sold is what Bioverge Funds, Modulo I, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.